BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate
May 15, 2024 08:00 ET
|
BranchOut Food Inc.
BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate
Stryve Foods, Inc. Reports Fiscal 2024 First Quarter Results
May 14, 2024 16:15 ET
|
Stryve Foods, Inc.
Stryve Foods, Inc. Reports Fiscal 2024 First Quarter Results
SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products
May 14, 2024 16:01 ET
|
SKYX Platforms Corp.
SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023
Faruqi & Faruqi, LLP Reminds Innoviz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 14, 2024
May 14, 2024 15:38 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Innoviz Technologies Ltd. (“Innoviz” or the...
BranchOut Food Secures Large Scale Production Facility in Peru Capable of $40M in Production Capacity; Estimated 40-50% Gross Margins
May 14, 2024 08:00 ET
|
BranchOut Food Inc.
BranchOut Food Secures Large Scale Production Facility in Peru Capable of $40M in Production Capacity; Estimated 40-50% Gross Margins
Rani Therapeutics to Participate in May Investor Conferences
May 14, 2024 08:00 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 13, 2024 17:01 ET
|
Turnstone Biologics Corp.
Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Cardiff Oncology to Present at Upcoming Investor Conferences in May
May 13, 2024 16:05 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
Company Name Change to NAPC Defense, Inc. (OTCPK: BLIS) and Website to NAPCDefense.com among Business Updates
May 13, 2024 08:05 ET
|
Treasure & Shipwreck Recovery, Inc.
NAPC Defense (OTCPK:BLIS) completes name change, is set for Saudi Arabia Corner Shot Weapons and other NAPC New Arms Technologies Presentation
Oncocyte to Announce First Quarter 2024 Financial Results
May 13, 2024 08:00 ET
|
OncoCyte Corporation
Oncocyte to Announce First Quarter 2024 Financial Results